Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADCT | MREO | MXCT | ||
| Company | Adc Therapeutics Sa | Mereo Biopharma Group Plc ADR | Maxcyte Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 4.96 | 3.16 | 3.95 | ||
| High | 5.11 | 3.35 | 3.95 | ||
| Low | 4.81 | 3.14 | 3.74 | ||
| Last | 4.90 | 3.26 | 3.77 | ||
| Change | +0.17 | +0.15 | -0.06 | ||
| % Change | +3.59% | +4.82% | -1.57% | ||
| Volume | 323,200 | 855,500 | 477,800 | ||
| 20-Day Average Volume | 400,625 | 947,290 | 461,460 | ||
| Previous Close | 4.73 | 3.11 | 3.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.67 | 2.86 | 3.89 | ||
| 20-Day Raw Stochastic | 62.20% | 89.09% | 30.53% | ||
| 20-Day Relative Strength | 55.72% | 56.82% | 40.50% | ||
| Weighted Alpha | +73.59 | +93.22 | -24.51 | ||
| Today's Opinion | 100% Buy | 64% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 96% Buy | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.90% since 04/26/24 | +18.98% since 04/26/24 | +1.62% since 04/26/24 | ||
| Low | 4.30 on 04/29/24 | 2.67 on 04/29/24 | 3.57 on 04/30/24 | ||
| High | 5.11 on 05/03/24 | 3.35 on 05/03/24 | 3.95 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +10.61% since 04/03/24 | -4.40% since 04/03/24 | -11.29% since 04/03/24 | ||
| Low | 4.11 on 04/15/24 | 2.53 on 04/18/24 | 3.57 on 04/30/24 | ||
| High | 5.38 on 04/08/24 | 3.47 on 04/04/24 | 4.27 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +36.11% since 02/02/24 | -17.26% since 02/02/24 | -26.80% since 02/02/24 | ||
| Low | 3.23 on 03/13/24 | 2.53 on 04/18/24 | 3.57 on 04/30/24 | ||
| High | 6.04 on 02/20/24 | 4.36 on 02/05/24 | 5.11 on 02/05/24 | ||
| 6-Month | |||||
| %Chg | +512.50% since 11/03/23 | +55.98% since 11/03/23 | +10.23% since 11/03/23 | ||
| Low | 0.36 on 11/13/23 | 1.86 on 11/28/23 | 3.15 on 11/10/23 | ||
| High | 6.04 on 02/20/24 | 4.36 on 02/05/24 | 5.55 on 01/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 405,789 | 407,454 | 394,131 | ||
| Shares Outstanding, K | 82,814 | 124,986 | 104,544 | ||
| Annual Sales | 69,560,000 | 10,000,000 | 41,290,000 | ||
| Annual Net Income | -240,050,000 | -29,470,000 | -37,920,000 | ||
| Last Quarter Sales | 16,790,000 | N/A | 15,660,000 | ||
| Last Quarter Net Income | -85,700,000 | N/A | -5,280,000 | ||
| 60-Month Beta | 1.69 | 0.88 | 1.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 03/13/24 | N/A | -0.05 on 03/12/24 | ||
| Latest Earnings Date | 05/06/24 | 06/26/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||